The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.
Cancer, Immunology And Microbiology, Pulmonology, Research, School of Medicine, Strategic Plan, Vascular Health, Vital Signs
Paola A. Gehrig, MD, will begin her new role on June 27. She completed her residency in obstetrics and gynecology at the University of Virginia.
Cancer, Obstetrics and Gynecology, School of Medicine, Vital Signs
This research, led by Jean Cook, PhD, and Liu Mei, PhD, at the UNC School of Medicine, may help explain why certain parts of the genome become highly mutable in…
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center’s inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast…
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.
Awards, Rankings and Recognitions, Cancer, Oncology, School of Medicine, Surgery, UNC Health, Vital Signs
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
Awards, Rankings and Recognitions, Cancer, Research, School of Medicine
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious…
Announcements, Awards, Rankings and Recognitions, Bioinformatics, Cancer, Clinical Research, Covid-19 / Coronavirus, Diversity, Equity and Inclusion, Education, Events, Faculty, General Medicine, Global Health, Health Sciences, Infectious Diseases, Neurology, News, North Carolina, Oncology, Physical Medicine & Rehabilitation, Physical Therapy, Pulmonology, Research, School of Medicine, Technology and Innovation, UNC Health, Vital Signs, Wellness
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel…
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.
Dr. Rumey Ishizawar, Medical Director of the UNC Rheumatology Clinic, founded the multi-disciplinary UNC Immuno-Oncology Group (IOG) in 2017 to optimize clinical management of cancer patients who develop immune related…
Gynecologic Cancers: A Team Approach to Women’s Health Care. Please join the UNC Lineberger Cancer Network for the NC Community College lecture with Daniel Clarke-Pearson, MD, and Lyn Filip, RN,…
Linda Kelly, a 66-year-old mother of four daughters, was diagnosed with breast cancer 20 years ago and received treatment that included a mastectomy and radiation. The medical intervention saved her…
Expertscape, an online database that assesses and ranks the expertise and contributions of physicians and medical institutions worldwide, ranked Lisa Carey, MD, as one of the top 10 breast cancer…
New research by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer….
One in seven black women with breast cancer had delays in starting treatment, and black women also had extended duration of treatment, according to a study led by UNC Lineberger…
A team of researchers from the UNC School of Medicine Department of Family Medicine and Lineberger Comprehensive Cancer Center have received new funding to develop and test messaging to co-users…
